ReviewFrontiers in pharmacology2026

Pradefovir mesylate and tenofovir amibufenamide for chronic hepatitis B: a systematic review and pragmatic treatment algorithm.

Shuqi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.